Kamihagi K, Katayama M, Ouchi R, Kato I
Cell Technology Reagent Section, Takara Shuzo Co., Ltd., Shiga, Japan.
Biochem Biophys Res Commun. 1994 Apr 15;200(1):423-8. doi: 10.1006/bbrc.1994.1466.
Osteonectin (OTN) has been implicated in controlling cell adhesivity onto substratum and extracellular matrix (ECM) remodeling. Significant amounts of OTN were synthesized not only by normal fibroblasts and endothelial cells, but also by HT-1080 fibrosarcoma and MG-63 osteosarcoma cells. Levels of secreted OTN were likely to be slightly elevated by the addition of exogenous placental laminin (LN), but not by supplementation of plasma fibronectin (FN). Exogenously supplemented purified bone OTN was not apparently incorporated into the ECM of the adhering cells and had no effect on cell spreading and growth, whereas secretion of type I collagen or FN in the tumor cells was moderately diminished in the presence of soluble OTN. Concentration-dependent down-regulation of cellular LN secretion appeared to be most significant, suggesting that OTN participates in regulating extracellular secretion of ECM components in the cells either with or without the ability to synthesize cellular OTN.
骨连接蛋白(OTN)与控制细胞在基质上的黏附性以及细胞外基质(ECM)重塑有关。不仅正常成纤维细胞和内皮细胞会合成大量的OTN,HT - 1080纤维肉瘤细胞和MG - 63骨肉瘤细胞也会合成。添加外源性胎盘层粘连蛋白(LN)可能会使分泌的OTN水平略有升高,但补充血浆纤连蛋白(FN)则不会。外源性补充的纯化骨OTN显然不会掺入黏附细胞的ECM中,对细胞铺展和生长也没有影响,而在可溶性OTN存在的情况下,肿瘤细胞中I型胶原蛋白或FN的分泌会适度减少。细胞LN分泌的浓度依赖性下调似乎最为显著,这表明OTN参与调节细胞中ECM成分的细胞外分泌,无论这些细胞是否具有合成细胞OTN的能力。